Alzheimer s Disease Pilot Clinical Trials (R01)

The summary for the Alzheimer s Disease Pilot Clinical Trials (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Alzheimer s Disease Pilot Clinical Trials (R01): -In 1999, at the direction of Congress, the National Institute on Aging (NIA), in conjunction with the National Institute of Neurological Disorders and Stroke (NINDS), the National Institute of Mental Health (NIMH), and the National Institute of Nursing Research (NINR) embarked on the Alzheimer's Disease (AD) Prevention Initiative, which encompasses a number of interrelated efforts including basic, epidemiological, behavioral, and clinical research. An important part of the AD Prevention Initiative is to quicken the pace for translating basic science findings into clinical trials to evaluate treatment and prevention strategies. This funding opportunity announcement (FOA) focuses on AD pilot clinical trials while other FOAs are targeted to AD drug discovery and development. -In this FOA the National Institute on Aging (NIA), the National Center for Complementary and Alternative Medicine (NCCAM), and the National Institute of Nursing research (NINR) invite qualified investigators to submit research grant applications for pilot clinical trials using pharmacologic and/or behavioral interventions directed toward the prevention and treatment of the cognitive and behavioral symptoms of mild cognitive impairment (MCI), Alzheimer's disease (AD), and age-related cognitive decline.

Federal Grant Title:	Alzheimer s Disease Pilot Clinical Trials (R01)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Education Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAR-08-062
Type of Funding:	Grant
CFDA Numbers:	93.213
CFDA Descriptions:	Research and Training in Complementary and Alternative Medicine
Current Application Deadline:	Jan 07, 2011
Original Application Deadline:	Jan 07, 2011
Posted Date:	Dec 27, 2007
Creation Date:	Dec 05, 2008
Archive Date:	Feb 07, 2011
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants: • Mind and Body Interventions to Restore Whole Person Health via Emotional Well-Being Mechan...; • Limited Competition: Advancing the Science of Complementary and Integrative Health Approac...; • HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clin...; • HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R33 Clinical...; • Model Continuums of Care Initiative (MCCI) to Advance Health Equity and End Health Dispari...; • Probiotics for Pediatric Illnesses; • Cam Practitioner Research Education Project Grant Partnership; • Complementary and Alternative Medicine Career Transition Award (K22)
More Grants from the National Institutes of Health: • NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional); • Single Source Renewal for the Continuation of the Liver Cirrhosis Network: Scientific and ...; • NIGMS Institutional Biomedical Undergraduate Research Training (BURT) Program (T34); • Limited Competition: Outcomes of Electronic Medical Records and Genomics (eMERGE) Genomic ...; • Maximizing Investigators' Research Award (MIRA) (R35 - Clinical Trial Optional)